Tenaya Gene Therapy Shows Strong Arrhythmia Reduction in ARVC Trial
SOUTH SAN FRANCISCO, Calif., May 15, 2026 Tenaya Therapeutics reported encouraging interim Phase 1b/2 clinical data for TN-401, its...
Gene Therapy
Advertisement
AviadoBio Advances AVB-406 Gene Therapy for Alzheimer’s
LONDON, May 14, 2026 AviadoBio presented new preclinical data at the American Society of Gene and Cell Therapy (ASGCT)...
GEMMABio Expands Gene Therapy Pipeline for Rare Diseases
PHILADELPHIA, May 14, 2026 GEMMA Biotherapeutics (GEMMABio) unveiled its new Duchenne muscular dystrophy (DMD) gene therapy program and presented...
Encoded Therapeutics Reports Strong ETX101 Results
SOUTH SAN FRANCISCO, Calif. – May 13, 2026 Encoded Therapeutics presented expanded clinical data from its ongoing POLARIS Phase...
Sana Biotechnology Advances In Vivo CAR T Platform
SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...
Advertisements
Neurogene Highlights Rett Gene Therapy Progress at ASGCT
NEW YORK, May 12, 2026 Neurogene presented new data at the 2026 American Society of Gene and Cell Therapy...
Encoded Therapeutics Expands CNS Gene Therapy Pipeline
SOUTH SAN FRANCISCO, Calif., May 12, 2026 Encoded Therapeutics announced new preclinical findings at the 2026 American Society of...
AskBio Expands Rare Disease Pipeline With AB-1009 Pompe Trial Milestone
DURHAM, N.C., May 11, 2026 AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary...
AIRNA Showcases RNA Editing Advances at ASGCT 2026
CAMBRIDGE, Mass., May 12, 2026 AIRNA announced new preclinical findings at the 2026 American Society of Gene and Cell...
Dark Horse Consulting and KunTuo Partner to Accelerate CGT Trials
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
Advertisement
